News and Events

Canada’s Drug Agency is taking a new step to improve the timeliness of patient access to new drugs. The action supports our ambitious Target Zero camp ...

A new evidence report from Canada’s Drug Agency identifies key factors that influence the ability of older adults in Canada to age in place and the ...

Current consultation status: Open Consultation period: July 11, 2024, to September 11, 2024 Canada’s Drug Agency is developing pan-Canadian guidance to ...

Canada’s Drug Agency is advancing our commitment to building meaningful relationships with patient communities by establishing a new Patient Member ...

Canada’s Drug Agency is announcing recent and upcoming changes to the leadership of our Canadian Drug Expert Committee (CDEC), pan-Canadian Oncology ...

Canada’s Drug Agency is launching a new 1-year learning period in our Scientific Advice program that will expand the type of guidance we offer to drug ...